The Weight of Cardiovascular Diseases: Addressing the Global Cardiovascular Crisis Associated with Obesity
By: Francisco Lopez-Jimenez, Mariachiara Di Cesare, Jaynaide Powis, Shreya Shrikhande, Marvellous Adeoye, Elisa Codato, Bin Zhou, Honor Bixby, Natalie Evans, Kyla Lara-Breitinger, Mariana Arellano Rodriguez, Lisa Hadeed, Simon Barquera, Sean Taylor, Pablo Perel, Daniel Piñeiro, Jagat Narula and Fausto J. Pinto
References
- World Health Organization. Obesity and overweight; 2025 [cited 2025 Jun 6]. Available from:
https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight - NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in underweight and obesity from 1990 to 2022: A pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet. 2024;403(10431):1027–1050. Available from:
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)02750-2/fulltext?gsid=dc68881c-0975-41a5-977f-2c7c62550dc5 - GBD 2021 Adult BMI Collaborators. Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: A forecasting study for the Global Burden of Disease Study 2021. Lancet. 2025;405(10481):813–838. Available from:
https://www.sciencedirect.com/science/article/pii/S0140673625003551 - Jayaraj RL, Aburawi EH. Mechanistic relationship between obesity-induced inflammation triggering endothelial dysfunction and the initiation of atherosclerosis development. Heart, Vessels and Transplant. 2025;9(1):
art542 . DOI: 10.24969/hvt.2024.542 - Lopez-Jimenez F, Almahmeed W, Bays H, Cuevas A, Di Angelantonio E, le Roux CW, et al. Obesity and cardiovascular disease: Mechanistic insights and management strategies. A joint position paper by the World Heart Federation and World Obesity Federation. European Journal of Preventive Cardiology. 2022;29(17):2218–2237. DOI: 10.1093/eurjpc/zwac187
- Institute for Health Metrics and Evaluation (IHME). GBD compare data visualization; 2024 [cited 2025 Mar 11]. Available from:
http://vizhub.healthdata.org/gbd-compare - Popkin BM, Corvalan C, Grummer-Strawn LM. Dynamics of the double burden of malnutrition and the changing nutrition reality. Lancet. 2020;395(10217):65–74. DOI: 10.1016/S0140-6736(19)32497-3
- Okunogbe A, Nugent R, Spencer G, Powis J, Ralston J, Wilding J. Economic impacts of overweight and obesity: Current and future estimates for 161 countries. BMJ Global Health. 2022;7(9). DOI: 10.1136/bmjgh-2022-009773
- World Obesity Federation Global Obesity Observatory. Economic impact of overweight and obesity; 2019 [cited 2025 Jun 6]. Available from:
https://data.worldobesity.org/economic-impact-new/#:~:text=If%20current%20trends%20continue%2C%20using,%3E%203%25%20of%20GDP%20globally - World Obesity Federation. Economic impact of overweight and obesity to surpass $4 trillion by 2035; 2023 [cited 2025 Jun 6]. Available from:
https://www.worldobesity.org/news/economic-impact-of-overweight-and-obesity-to-surpass-4-trillion-by-2035 - Rubino F, Puhl RM, Cummings DE, Eckel RH, Ryan DH, Mechanick JI, et al. Joint international consensus statement for ending stigma of obesity. Nature Medicine. 2020;26(4):485–497. DOI: 10.1038/s41591-020-0803-x
- Puhl RM, Lessard LM, Himmelstein MS, Foster GD. The roles of experienced and internalized weight stigma in healthcare experiences: Perspectives of adults engaged in weight management across six countries. PLoS One. 2021;16(6):
e0251566 . DOI: 10.1371/journal.pone.0251566 - Phelan SM, Burgess DJ, Yeazel MW, Hellerstedt WL, Griffin JM, van Ryn M. Impact of weight bias and stigma on quality of care and outcomes for patients with obesity. Obesity Reviews. 2015;16(4):319–326. DOI: 10.1111/obr.12266
- World Heart Report 2025. World Heart Report 2025; 2025 [cited 2025 Jun 6]. Available from:
https://world-heart-federation.org/report2025/ - Data Downloads > NCD-RisC. [cited 2025 Jun 6]. Available from:
https://www.ncdrisc.org/data-downloads.html - Global Health Data Exchange. Global Burden of Disease Study 2021(GBD 2021) Data Resources; 2021 [cited 2025 Jun 6]. Available from:
https://ghdx.healthdata.org/gbd-2021 - Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: A report of the American college of cardiology/American heart association task force on clinical practice guidelines: A report of the American college of cardiology/American heart association task force on clinical practice guidelines. Circulation. 2019;140(11):e596–e646. DOI: 10.1161/CIR.0000000000000678
- Apovian CM, Aronne LJ, Bessesen DH, McDonnell ME, Murad MH, Pagotto U, et al. Pharmacological management of obesity: An endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism. 2015;100(2):342–362. DOI: 10.1210/jc.2014-3415
- NICE. Guidance: Overview. Overweight and obesity management; 2025 [cited 2025 Jun 9]. Available from:
https://www.nice.org.uk/guidance/ng246 - Flint SW. Rethinking the label anti-obesity medication. The Lancet Diabetes & Endocrinology. 2024;12(5):301–302. DOI: 10.1016/S2213-8587(24)00071-8
- Khera R, Murad MH, Chandar AK, Dulai PS, Wang Z, Prokop LJ, et al. Association of pharmacological treatments for obesity with weight loss and adverse events: A systematic review and meta-analysis. JAMA. 2016;315(22):2424–2434. DOI: 10.1001/jama.2016.7602
- Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al. Once-weekly semaglutide in adults with overweight or obesity. The New England Journal of Medicine. 2021;384(11):989–1002. DOI: 10.1056/NEJMoa2032183
- Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, et al. Tirzepatide once weekly for the treatment of obesity. The New England Journal of Medicine. 2022;387(3):205–216. DOI: 10.1056/NEJMoa2206038
- Lincoff AM, Brown-Frandsen K, Colhoun HM, Deanfield J, Emerson SS, Esbjerg S, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes. The New England Journal of Medicine. 2023;389(24):2221–2232. DOI: 10.1056/NEJMoa2307563
- Drucker DJ. Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metabolism. 2018;27(4):740–756. DOI: 10.1016/j.cmet.2018.03.001
- Packer M, Zile MR, Kramer CM, Baum SJ, Litwin SE, Menon V, et al. Tirzepatide for heart failure with preserved ejection fraction and obesity. The New England Journal of Medicine. 2025;392(5):427–437. DOI: 10.1056/NEJMoa2410027
- Kosiborod MN, Abildstrøm SZ, Borlaug BA, Butler J, Rasmussen S, Davies M, et al. Semaglutide in patients with heart failure with preserved ejection fraction and obesity. The New England Journal of Medicine. 2023;389(12):1069–1084. DOI: 10.1056/NEJMoa2306963
- Badve SV, Bilal A, Lee MMY, Sattar N, Gerstein HC, Ruff CT, et al. Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: A meta-analysis of randomised controlled trials. The Lancet Diabetes & Endocrinology. 2025;13(1):15–28. DOI: 10.1016/S2213-8587(24)00271-7
- Gloy VL, Briel M, Bhatt DL, Kashyap SR, Schauer PR, Mingrone G, et al. Bariatric surgery versus non-surgical treatment for obesity: A systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;347:
f5934 . DOI: 10.1136/bmj.f5934 - Salminen P, Grönroos S, Helmiö M, Hurme S, Juuti A, Juusela R, et al. Effect of laparoscopic sleeve gastrectomy vs Roux-en-Y gastric bypass on weight loss, comorbidities, and reflux at 10 years in adult patients with obesity: The SLEEVEPASS randomized clinical trial: The SLEEVEPASS randomized clinical trial. JAMA Surgery. 2022;157(8):656–666. DOI: 10.1001/jamasurg.2022.2229
- World Health Organization. WHO acceleration plan to stop obesity. Genève, Switzerland: World Health Organization; 2023 . p.
20 . Available from:https://play.google.com/store/books/details?id=86IOEQAAQBAJ - Sawyer A, den Hertog K, Verhoeff AP, Busch V, Stronks K. Developing the logic framework underpinning a whole-systems approach to childhood overweight and obesity prevention: Amsterdam Healthy Weight Approach. Obesity Science & Practice. 2021;7(5):591–605. DOI: 10.1002/osp4.505
- DOF – Diario Oficial de la Federación; [cited 2025 Jun 9]. Available from:
https://www.dof.gob.mx/nota_detalle.php?codigo=5325371&fecha=11/12/2013#gsc.tab=0 - Sánchez-Romero LM, Penko J, Coxson PG, Fernández A, Mason A, Moran AE, et al. Projected impact of Mexico’s sugar-sweetened beverage tax policy on diabetes and cardiovascular disease: A modeling study. PLoS Medicine. 2016;13(11):
e1002158 . DOI: 10.1371/journal.pmed.1002158 - Miyoshi M, Tsuboyama-Kasaoka N, Nishi N. School-based “Shokuiku” program in Japan: Application to nutrition education in Asian countries. Asia Pacific Journal of Clinical Nutrition. 2012;21(1):159–162. Available from:
https://pubmed.ncbi.nlm.nih.gov/22374574/ - Global Health Advocacy Incubator. Brazil implements front-of-package warning labels; 2022 [cited 2025 Mar 11]. Available from:
https://www.advocacyincubator.org/news/2022-11-08-brazil-implements-front-of-package-warning-labels#:~:text=These%20efforts%20culminated%20with%20the,sugar%2C%20saturated%20fats%20and%20sodium - Senda MVG, Raposo A, Teixeira-Lemos E, Chaves C, Alturki HA, Alsharari ZD, et al. Brazilian front-of-package labeling: A product compliance analysis 12 months after implementation of regulations. Nutrients. 2024;16(3). DOI: 10.3390/nu16030343
- U.S. Department of Agriculture-Rural Development. Healthy food financing initiative [cited 2025 Mar 11]. Available from:
https://www.rd.usda.gov/about-rd/initiatives/healthy-food-financing-initiative#:~:text=The%20HFFI%20Program%20provides%20funding,through%20SNAP%20eligible%20food%20retailers - ARC. ARC – NIHR Banning new takeaways in Gateshead to reduce childhood obesity. 2024 [cited 2025 Jun 10]. Available from:
https://arc-nenc.nihr.ac.uk/evidence/did-banning-new-takeaways-in-gateshead-have-any-impact-on-child-health/ - Brown H, Xiang H, Albani V, Goffe L, Akhter N, Lake A, et al. No new fast-food outlets allowed! Evaluating the effect of planning policy on the local food environment in the North East of England. Social Science & Medicine. 2022;306(115126):
115126 . DOI: 10.1016/j.socscimed.2022.115126 - Food Safety and Standards Authority of India. Eat Right India [cited 2025 Mar 11]. Available from:
https://eatrightindia.gov.in/eatrightindia.jsp - Kaladharan S, Dhanya M, Rejikumar G. Transforming food systems: A case of Eat Right India. International Journal of Health Governance. 2023;28(4):453–465. DOI: 10.1108/IJHG-05-2023-0048
- Finnish National Agency for Education. School meals in Finland; 2025 [cited 2025 Mar 11]. Available from:
https://www.oph.fi/en/education-and-qualifications/school-meals-finland - Ford ND, Patel SA, Narayan KMV. Obesity in low- and middle-income countries: Burden, drivers, and emerging challenges. Annual Review of Public Health. 2017;38:145–164. DOI: 10.1146/annurev-publhealth-031816-044604
- Chung ST, Krenek A, Magge SN. Childhood obesity and cardiovascular disease risk. Current Atherosclerosis Reports. 2023;25(7):405–415. DOI: 10.1007/s11883-023-01111-4
- Chavez-Ugalde Y, Jago R, Toumpakari Z, Egan M, Cummins S, White M, et al. Conceptualizing the commercial determinants of dietary behaviors associated with obesity: A systematic review using principles from critical interpretative synthesis. Obesity Science & Practice. 2021;7(4):473–486. DOI: 10.1002/osp4.507
- Gilmore AB, Fabbri A, Baum F, Bertscher A, Bondy K, Chang HJ, et al. Defining and conceptualising the commercial determinants of health. Lancet. 2023;401(10383):1194–1213. DOI: 10.1016/S0140-6736(23)00013-2
- Loos RJF, Yeo GSH. The genetics of obesity: from discovery to biology. Nature Reviews Genetics. 2022;23(2):120–133. DOI: 10.1038/s41576-021-00414-z
- Bleich SN, Vercammen KA, Zatz LY, Frelier JM, Ebbeling CB, Peeters A. Interventions to prevent global childhood overweight and obesity: A systematic review. The Lancet Diabetes & Endocrinology. 2018;6(4):332–346. DOI: 10.1016/S2213-8587(17)30358-3
- World Health Organization. Report of the commission on ending childhood obesity. WHO; 2016 [cited 2025 Jun 9]. Available from:
https://www.who.int/publications/i/item/9789241510066 - Davies AL, Spiga F, Caldwell DM, Savovi J, Palmer JC, Tomlinson E, et al. Factors associated with the effectiveness of interventions to prevent obesity in children: A synthesis of evidence from 204 randomised trials. BMJ Public Health. 2025;3(1):
e001707 . DOI: 10.1136/bmjph-2024-001707 - World Health Organisation. Global action plan for the prevention and control of noncommunicable diseases 2013–2020; 2013 [cited 2025 Mar 11]. Available from:
https://www.who.int/publications/i/item/9789241506236 - Misra A, Khurana L. Obesity-related non-communicable diseases: South Asians vs White Caucasians. International Journal of Obesity (London). 2011;35(2):167–187. DOI: 10.1038/ijo.2010.135
- Editorial. Redefining obesity: advancing care for better lives. The Lancet Diabetes & Endocrinology. 2025;13(2):
75 . DOI: 10.1016/S2213-8587(25)00004-X
DOI: https://doi.org/10.5334/gh.1451 | Journal eISSN: 2211-8179
Language: English
Submitted on: Jul 4, 2025
Accepted on: Jul 14, 2025
Published on: Aug 21, 2025
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2025 Francisco Lopez-Jimenez, Mariachiara Di Cesare, Jaynaide Powis, Shreya Shrikhande, Marvellous Adeoye, Elisa Codato, Bin Zhou, Honor Bixby, Natalie Evans, Kyla Lara-Breitinger, Mariana Arellano Rodriguez, Lisa Hadeed, Simon Barquera, Sean Taylor, Pablo Perel, Daniel Piñeiro, Jagat Narula, Fausto J. Pinto, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.